Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Experian PLC stock logo
EXPGY
Experian
$52.99
+1.2%
$51.32
$39.08
$53.76
$48.10B1.2280,103 shs86,639 shs
Glencore PLC stock logo
GLNCY
Glencore
$8.23
+3.0%
$7.46
$5.74
$12.44
$47.67B0.99789,088 shs826,765 shs
Givaudan SA stock logo
GVDNY
Givaudan
$97.03
+0.5%
$98.75
$81.37
$110.32
$44.58B0.7515,791 shs13,098 shs
Recordati Industria Chimica E Farmaceutica S.P.A. stock logo
RCDTF
Recordati Industria Chimica E Farmaceutica
$65.44
$59.24
$49.00
$65.44
N/A0.2215 shsN/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Experian PLC stock logo
EXPGY
Experian
+0.21%+1.95%+2.55%+28.65%+11.45%
Glencore PLC stock logo
GLNCY
Glencore
-3.97%+2.70%+3.23%+36.35%-35.23%
Givaudan SA stock logo
GVDNY
Givaudan
-0.90%-0.30%-4.87%+17.53%+1.26%
Recordati Industria Chimica E Farmaceutica S.P.A. stock logo
RCDTF
Recordati Industria Chimica E Farmaceutica
0.00%0.00%+16.77%+21.19%+26.82%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Experian PLC stock logo
EXPGY
Experian
1.1642 of 5 stars
0.05.01.70.00.00.01.3
Glencore PLC stock logo
GLNCY
Glencore
2.884 of 5 stars
0.03.01.70.02.50.03.1
Givaudan SA stock logo
GVDNY
Givaudan
N/AN/AN/AN/AN/AN/AN/AN/A
Recordati Industria Chimica E Farmaceutica S.P.A. stock logo
RCDTF
Recordati Industria Chimica E Farmaceutica
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Experian PLC stock logo
EXPGY
Experian
3.00
BuyN/AN/A
Glencore PLC stock logo
GLNCY
Glencore
4.00
Strong BuyN/AN/A
Givaudan SA stock logo
GVDNY
Givaudan
2.33
HoldN/AN/A
Recordati Industria Chimica E Farmaceutica S.P.A. stock logo
RCDTF
Recordati Industria Chimica E Farmaceutica
1.50
ReduceN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Experian PLC stock logo
EXPGY
Experian
$7.52B6.47$2.42 per share21.93$5.54 per share9.56
Glencore PLC stock logo
GLNCY
Glencore
$230.94B0.21$1.14 per share7.19$5.85 per share1.41
Givaudan SA stock logo
GVDNY
Givaudan
$8.42B5.32$3.58 per share27.08$11.26 per share8.62
Recordati Industria Chimica E Farmaceutica S.P.A. stock logo
RCDTF
Recordati Industria Chimica E Farmaceutica
$2.53BN/A$3.06 per share21.39N/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Experian PLC stock logo
EXPGY
Experian
$1.17BN/A0.0030.112.51N/AN/AN/AN/A
Glencore PLC stock logo
GLNCY
Glencore
-$1.63BN/A0.009.140.72N/AN/AN/A8/6/2025 (Estimated)
Givaudan SA stock logo
GVDNY
Givaudan
$1.24BN/A0.0032.455.02N/AN/AN/A7/22/2025 (Estimated)
Recordati Industria Chimica E Farmaceutica S.P.A. stock logo
RCDTF
Recordati Industria Chimica E Farmaceutica
$450.70M$2.0032.72N/AN/AN/AN/A7/29/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Experian PLC stock logo
EXPGY
Experian
$0.811.53%N/AN/AN/A
Glencore PLC stock logo
GLNCY
Glencore
$0.172.07%N/AN/AN/A
Givaudan SA stock logo
GVDNY
Givaudan
$0.960.99%N/AN/AN/A
Recordati Industria Chimica E Farmaceutica S.P.A. stock logo
RCDTF
Recordati Industria Chimica E Farmaceutica
N/AN/AN/AN/AN/A

Latest RCDTF, GVDNY, EXPGY, and GLNCY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/17/2025
Experian PLC stock logo
EXPGY
Experian
$0.40751.14%6/20/20256/23/20257/18/2025
4/29/2025
Glencore PLC stock logo
GLNCY
Glencore
$0.08502.75%5/2/20255/5/20256/18/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Experian PLC stock logo
EXPGY
Experian
0.87
0.71
0.71
Glencore PLC stock logo
GLNCY
Glencore
0.77
1.20
0.60
Givaudan SA stock logo
GVDNY
Givaudan
0.86
1.49
0.98
Recordati Industria Chimica E Farmaceutica S.P.A. stock logo
RCDTF
Recordati Industria Chimica E Farmaceutica
1.16
1.61
1.06

Institutional Ownership

CompanyInstitutional Ownership
Experian PLC stock logo
EXPGY
Experian
0.34%
Glencore PLC stock logo
GLNCY
Glencore
0.06%
Givaudan SA stock logo
GVDNY
Givaudan
0.01%
Recordati Industria Chimica E Farmaceutica S.P.A. stock logo
RCDTF
Recordati Industria Chimica E Farmaceutica
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Experian PLC stock logo
EXPGY
Experian
23,300918.72 million917.75 millionNot Optionable
Glencore PLC stock logo
GLNCY
Glencore
150,0005.97 billionN/ANot Optionable
Givaudan SA stock logo
GVDNY
Givaudan
16,942461.68 millionN/ANot Optionable
Recordati Industria Chimica E Farmaceutica S.P.A. stock logo
RCDTF
Recordati Industria Chimica E Farmaceutica
4,583N/AN/ANot Optionable

Recent News About These Companies

Recordati e Amarin, accordo per Vazkepa in 59 Paesi
Grey firma il nuovo spot Recordati per Eumill
Piazza Affari: performance negativa per Recordati
Recordati, JP Morgan alza il target price
Recordati brilla grazie alla promozione di Jp Morgan
Campari e Recordati si Staccano dal FTSE MIB

New MarketBeat Followers Over Time

Media Sentiment Over Time

Experian stock logo

Experian OTCMKTS:EXPGY

$52.99 +0.63 (+1.20%)
As of 03:58 PM Eastern

Experian plc, together with its subsidiaries, operates as a technology company in North America, Latin America, the United Kingdom, Ireland, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Business-to-Business and Consumer Services. The company collects, sorts, aggregates, and transforms data from various sources to provide a range of data-driven services. It also owns, create, and develops analytics, predictive tools, sophisticated software, and platforms; credit risk, fraud prevention, identity management, customer service and engagement, account processing, and account management services; data analysis, and research and development services. In addition, the company provides credit education, free access to Experian credit reports and scores, and online educational tools. It serves its customers in financial service, direct-to-consumer, health, retail, automotive, software and professional services, telecoms and utility, insurance, media and technology, and other industries, as well as government and public sectors. The company was formerly known as Experian Group Limited and changed its name to Experian plc in July 2008. Experian plc was founded in 1826 and is headquartered in Dublin, Ireland.

Glencore stock logo

Glencore OTCMKTS:GLNCY

$8.23 +0.24 (+3.00%)
As of 03:59 PM Eastern

Glencore plc engages in the production, refinement, processing, storage, transport, and marketing of metals and minerals, and energy products in the Americas, Europe, Asia, Africa, and Oceania. It operates through two segments: Marketing Activities and Industrial Activities. The company engages in production and marketing copper, cobalt, lead, nickel, zinc, chrome ore, ferrochrome, vanadium, aluminum, alumina, and iron ore; and coal, crude oil, refined products, and natural gas, as well as oil exploration/production and refining/distribution. It also operates marketing and distribution of physical commodities sourced from third party producers and company's production to industrial consumers, including the battery, electronic, construction, automotive, steel, energy, and oil industries. In addition, the company provides financing, logistics, and other services to producers and consumers of commodities. Glencore plc was founded in 1974 and is headquartered in Baar, Switzerland.

Givaudan stock logo

Givaudan OTCMKTS:GVDNY

$97.03 +0.48 (+0.49%)
As of 03:50 PM Eastern

Givaudan SA manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products. The Taste & Wellbeing division provides beverages, such as fizzy drinks, bottled waters, ready-to-drink juices, alcoholic beverages, and others; dairy and cheese products, including dairy drinks, yoghurt, ice cream, chilled desserts, cream cheese, and spreads; snacks; givaudan flavour ingredients; savory, and supplements and nutraceutical products; and biscuits, crackers, and cereals, as well as confectionery products, such as chewing gums, chocolates, and sweets. It operates in Switzerland, Europe, Africa, the Middle East, North America, Latin America, and the Asia Pacific. Givaudan SA was founded in 1796 and is headquartered in Vernier, Switzerland.

Recordati Industria Chimica E Farmaceutica stock logo

Recordati Industria Chimica E Farmaceutica OTCMKTS:RCDTF

$65.44 0.00 (0.00%)
As of 07/7/2025

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. The company also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma. In addition, it offers SYLVANT for the treatment of idiopathic multicentric Castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment of oral mucositis due to chemo and radiation therapy. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.